Insufficient scRNA-seq data for expression of GSDMC at single-cell level.
Insufficient scRNA-seq data for expression of GSDMC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 100% | 2778.47 | 240 / 241 | 0% | 0 | 0 / 0 |
esophagus | 38% | 1757.05 | 555 / 1445 | 60% | 24.35 | 110 / 183 |
tonsil | 0% | 0 | 0 / 0 | 93% | 35.75 | 42 / 45 |
skin | 72% | 2767.79 | 1297 / 1809 | 10% | 1.38 | 48 / 472 |
lung | 1% | 4.78 | 8 / 578 | 72% | 16.51 | 828 / 1155 |
uterus | 1% | 27.55 | 2 / 170 | 67% | 29.98 | 307 / 459 |
bladder | 0% | 0 | 0 / 21 | 44% | 10.85 | 220 / 504 |
breast | 5% | 22.33 | 25 / 459 | 38% | 4.79 | 426 / 1118 |
ovary | 0% | 0 | 0 / 180 | 41% | 2.99 | 177 / 430 |
pancreas | 0% | 0 | 0 / 328 | 31% | 3.22 | 55 / 178 |
brain | 0% | 0.63 | 6 / 2642 | 23% | 1.40 | 161 / 705 |
muscle | 19% | 116.96 | 152 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.63 | 4 / 29 |
prostate | 10% | 74.61 | 25 / 245 | 2% | 0.12 | 11 / 502 |
thymus | 2% | 10.92 | 12 / 653 | 7% | 0.47 | 42 / 605 |
liver | 0% | 0 | 0 / 226 | 7% | 0.49 | 30 / 406 |
kidney | 0% | 0 | 0 / 89 | 7% | 0.66 | 66 / 901 |
intestine | 0% | 0 | 0 / 966 | 7% | 0.81 | 36 / 527 |
stomach | 1% | 4.16 | 2 / 359 | 5% | 0.52 | 13 / 286 |
heart | 4% | 15.54 | 35 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.16 | 2 / 230 |
adipose | 1% | 6.78 | 7 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.29 | 1 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 1.04 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0042742 | Biological process | defense response to bacterium |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
Gene name | GSDMC |
Protein name | Gasdermin-C (Melanoma-derived leucine zipper-containing extranuclear factor) [Cleaved into: Gasdermin-C, N-terminal (GSDMC-NT); Gasdermin-C, C-terminal (GSDMC-CT)] Gasdermin-C |
Synonyms | MLZE |
Description | FUNCTION: [Gasdermin-C]: This form constitutes the precursor of the pore-forming protein: upon cleavage, the released N-terminal moiety (Gasdermin-C, N-terminal) binds to membranes and forms pores, triggering pyroptosis. .; FUNCTION: [Gasdermin-C, N-terminal]: Pore-forming protein that causes membrane permeabilization and pyroptosis . Produced by the cleavage of gasdermin-D by caspase CASP8 in response to death signals . After cleavage, moves to the plasma membrane where it strongly binds to membrane inner leaflet lipids . Homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis . . |
Accessions | ENST00000646090.1 Q9BYG8 A0A2R8Y5J4 ENST00000619643.1 ENST00000642712.2 ENST00000276708.9 |